Finding a potential target in glioblastoma treatment, the extensively studied and versatile target is IL-13 receptor α2 (IL13Rα2) and it is attributed to its selective and high expression on glioblastoma (Gatto et al., 2021). The gene discussed is IL13RA2; the disease is glioblastoma.